Skip to main content

Table 3 Median age at the first, second, third, fourth and fifth dose of palivizumab dispensing

From: RSV prophylaxis use in high-risk infants in Western Australia, 2002-2013: a record linkage cohort study

Dose

Number of infants

Median age in days (IQR)

1st

271

39 (33–111)

2nd

191

67 (62–142)

3rd

106

96 (90–251)

4th

62

266 (121–372)

5th

47

318 (154–417)

  1. *IQR inter-quartile range